Epigenetic Modification: a Regulatory Mechanism in Essential Hypertension

Overview

Journal Hypertens Res

Specialty Cardiology & Vascular Diseases

Date 2019 Mar 15

PMID 30867575

Citations 33

Authors

Mohammed Arif

Sakthivel Sadayappan

Richard C Becker

Lisa J Martin

Elaine M Urbina

Affiliations

Soon will be listed here.

Abstract

Essential hypertension (EH) is a multifactorial disease of the cardiovascular system that is influenced by the interplay of genetic, epigenetic, and environmental factors. The molecular dynamics underlying EH etiopathogenesis is unknown; however, earlier studies have revealed EH-associated genetic variants. Nevertheless, this finding alone is not sufficient to explain the variability in blood pressure, suggesting that other risk factors are involved, such as epigenetic modifications. Therefore, this review highlights the potential contribution of well-defined epigenetic mechanisms in EH, specifically, DNA methylation, post-translational histone modifications, and microRNAs. We further emphasize global and gene-specific DNA methylation as one of the most well-studied hallmarks among all epigenetic modifications in EH. In addition, post-translational histone modifications, such as methylation, acetylation, and phosphorylation, are described as important epigenetic markers associated with EH. Finally, we discuss microRNAs that affect blood pressure by regulating master genes such as those implicated in the renin-angiotensin-aldosterone system. These epigenetic modifications, which appear to contribute to various cardiovascular diseases, including EH, may be a promising research area for the development of novel future strategies for EH prevention and therapeutics.

Citing Articles

Diagnostic Utility of Combining Homocysteine, Lipoprotein-Associated Phospholipase A2, and the C-Reactive Protein-to-Albumin Ratio for Assessing Carotid Atherosclerosis and Plaque Stability in Patients with Essential Hypertension.

Yuan M, Feng L, Zhao D, Shi D, Wang H, Wei J Cardiovasc Toxicol. 2024; 25(1):24-33.

PMID: 39542955 DOI: 10.1007/s12012-024-09939-1.

Nasal turbinate lymphatic obstruction: a proposed new paradigm in the etiology of essential hypertension.

Phillips W, Schwartz J Front Med (Lausanne). 2024; 11:1380632.

PMID: 39219790 PMC: 11362006. DOI: 10.3389/fmed.2024.1380632.

A Multi-Omics Approach to Defining Target Organ Injury in Youth with Primary Hypertension.

Ananthamohan K, Brady T, Arif M, Daniels S, Falkner B, Ferguson M bioRxiv. 2024; .

PMID: 38948714 PMC: 11212900. DOI: 10.1101/2024.06.17.599125.

Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies.

Das D, Shruthi N, Banerjee A, Jothimani G, Duttaroy A, Pathak S Front Nutr. 2023; 10:1221438.

PMID: 37614749 PMC: 10442661. DOI: 10.3389/fnut.2023.1221438.

Based on network pharmacology, gastrodin attenuates hypertension-induced vascular smooth muscle cell proliferation and PI3K/AKT pathway activation.

Shen A, Wu M, Ali F, Guo Z, Fang Y, Zhou Y Sci Rep. 2023; 13(1):12140.

PMID: 37495624 PMC: 10372005. DOI: 10.1038/s41598-023-39202-6.

References

Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View

Coffman T . Under pressure: the search for the essential mechanisms of hypertension. Nat Med. 2011; 17(11):1402-9. DOI: 10.1038/nm.2541. View

Parati G, Ochoa J, Lombardi C, Bilo G . Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013; 10(3):143-55. DOI: 10.1038/nrcardio.2013.1. View

Lifton R, Gharavi A, Geller D . Molecular mechanisms of human hypertension. Cell. 2001; 104(4):545-56. DOI: 10.1016/s0092-8674(01)00241-0. View

Martinez-Aguayo A, Fardella C . Genetics of hypertensive syndrome. Horm Res. 2009; 71(5):253-9. DOI: 10.1159/000208798. View

Morgado J, Sanches B, Anjos R, Coelho C . Programming of Essential Hypertension: What Pediatric Cardiologists Need to Know. Pediatr Cardiol. 2015; 36(7):1327-37. DOI: 10.1007/s00246-015-1204-7. View

Griffin K . Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. Hypertension. 2017; 70(4):687-694. PMC: 5599324. DOI: 10.1161/HYPERTENSIONAHA.117.08314. View

Gasecki D, Kwarciany M, Nyka W, Narkiewicz K . Hypertension, brain damage and cognitive decline. Curr Hypertens Rep. 2013; 15(6):547-58. PMC: 3838597. DOI: 10.1007/s11906-013-0398-4. View

Munroe P, Barnes M, Caulfield M . Advances in blood pressure genomics. Circ Res. 2013; 112(10):1365-79. DOI: 10.1161/CIRCRESAHA.112.300387. View

10.

Timberlake D, OConnor D, Parmer R . Molecular genetics of essential hypertension: recent results and emerging strategies. Curr Opin Nephrol Hypertens. 2001; 10(1):71-9. DOI: 10.1097/00041552-200101000-00012. View

11.

Levy D, Ehret G, Rice K, Verwoert G, Launer L, Dehghan A . Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009; 41(6):677-87. PMC: 2998712. DOI: 10.1038/ng.384. View

12.

Newton-Cheh C, Johnson T, Gateva V, Tobin M, Bochud M, Coin L . Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009; 41(6):666-76. PMC: 2891673. DOI: 10.1038/ng.361. View

13.

Kato N, Takeuchi F, Tabara Y, Kelly T, Go M, Sim X . Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet. 2011; 43(6):531-8. PMC: 3158568. DOI: 10.1038/ng.834. View

14.

Kelly T, Takeuchi F, Tabara Y, Edwards T, Kim Y, Chen P . Genome-wide association study meta-analysis reveals transethnic replication of mean arterial and pulse pressure loci. Hypertension. 2013; 62(5):853-9. PMC: 3972802. DOI: 10.1161/HYPERTENSIONAHA.113.01148. View

15.

Evangelou E, Warren H, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H . Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018; 50(10):1412-1425. PMC: 6284793. DOI: 10.1038/s41588-018-0205-x. View

16.

Loscalzo J, Handy D . Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm Circ. 2014; 4(2):169-74. PMC: 4070783. DOI: 10.1086/675979. View

17.

Wise I, Charchar F . Epigenetic Modifications in Essential Hypertension. Int J Mol Sci. 2016; 17(4):451. PMC: 4848907. DOI: 10.3390/ijms17040451. View

18.

Lopez-Jaramillo P, Camacho P, Forero-Naranjo L . The role of environment and epigenetics in hypertension. Expert Rev Cardiovasc Ther. 2013; 11(11):1455-7. DOI: 10.1586/14779072.2013.846217. View

19.

Kato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W . Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet. 2015; 47(11):1282-1293. PMC: 4719169. DOI: 10.1038/ng.3405. View

20.

Stephens K, Miaskowski C, Levine J, Pullinger C, Aouizerat B . Epigenetic regulation and measurement of epigenetic changes. Biol Res Nurs. 2012; 15(4):373-81. PMC: 5839622. DOI: 10.1177/1099800412444785. View